Abstract
This International Alliance for Biological Standardization COVID-19 webinar was organized to provide an update on the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2, none months after COVID-19 was declared a public health emergency of international concern. It brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries.
Keywords:
Epidemiology; Immunology; SARS-CoV-2; Vaccine; Virology.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
MeSH terms
-
Antibodies, Neutralizing / biosynthesis
-
Antibodies, Viral / biosynthesis
-
Biological Products / isolation & purification
-
COVID-19 Vaccines* / administration & dosage
-
COVID-19 Vaccines* / adverse effects
-
COVID-19 Vaccines* / isolation & purification
-
COVID-19* / epidemiology
-
COVID-19* / etiology
-
COVID-19* / therapy
-
Clinical Trials as Topic
-
Drug Development / trends
-
Europe / epidemiology
-
Humans
-
Immunity, Cellular
-
Pandemics*
-
SARS-CoV-2* / genetics
-
SARS-CoV-2* / immunology
-
SARS-CoV-2* / pathogenicity
-
Safety
-
World Health Organization
Substances
-
Antibodies, Neutralizing
-
Antibodies, Viral
-
Biological Products
-
COVID-19 Vaccines